A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2002
11/27/2002	EP1260228A2 Human growth gene and short stature gene region. Therapeutic uses
11/27/2002	EP1259814A1 Bcmp-7 as marker for diagnosis of breast cancer
11/27/2002	EP1259813A2 Diagnosis and treatment of malignant neoplasms
11/27/2002	EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor
11/27/2002	EP1259648A2 Diagnostics and therapeutics for glaucoma
11/27/2002	EP1259642A1 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259639A2 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
11/27/2002	EP1259638A2 Methods for selectively modulating survivin apoptosis pathways
11/27/2002	EP1259626A2 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
11/27/2002	EP1259617A2 Bunyaviridal reaper proteins and uses therefor
11/27/2002	EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002	EP1259609A2 Human schizophrenia gene
11/27/2002	EP1259606A2 Compositions useful for regulating parkin gene activity
11/27/2002	EP1259605A2 Mutated cyclin g1 protein
11/27/2002	EP1259604A1 Bcmp 84, a protein associated to breast cancer
11/27/2002	EP1259603A2 Antisense oligonucleotides of the human chk1 gene and uses thereof
11/27/2002	EP1259546A1 Ccr2-64i, polymorphic variant of the human ccr2 receptor and its use in the diagnostic and treatment of atherosclerosis
11/27/2002	EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002	EP1259540A1 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259537A1 Gene expression system based on chimeric receptors
11/27/2002	EP1259531A2 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259527A1 35 human secreted proteins
11/27/2002	EP1259526A2 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259265A2 Nucleic acid formulations for gene delivery and methods of use
11/27/2002	EP1259264A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
11/27/2002	EP1259263A1 Complexation of rna, especially ribozymes, with polyethylenimines for the stabilization and cellular introduction thereof
11/27/2002	EP1259258A1 Gm-negative ehv-mutants
11/27/2002	EP1259254A1 Method of treatment of anorectal disorders
11/27/2002	EP1259253A2 Methods for promoting production of myelin by schwann cells
11/27/2002	EP1259251A2 Novel method for down-regulation of amyloid
11/27/2002	EP1259190A2 Method for making, loading and sealing a cell or drug encapsulation device, and such a device
11/27/2002	EP1246649A4 Intravascular delivery of nucleic acid
11/27/2002	EP1059931B1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
11/27/2002	EP0804210B1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells
11/27/2002	EP0776331B1 Higher order structure and binding of peptide nucleic acids
11/27/2002	EP0675961B1 Treatment of tumorigenic disease with a modified HSV
11/27/2002	EP0671928B1 Synthesis of n-substituted oligomers
11/27/2002	EP0630409B1 Defective packaging non-oncoviral vectors based on mpmv
11/27/2002	CN1382218A 溶瘤腺病毒 Oncolytic adenovirus
11/27/2002	CN1382216A DNA coding for beta-tubulin and use thereof
11/27/2002	CN1382211A Treatment of inflammatory or malignant disease using dnazymes
11/27/2002	CN1382158A Multiple cytokine-antibody complexes
11/27/2002	CN1382156A PABLO polypeptide that interacts with BCL-XL and uses related thereto
11/27/2002	CN1381584A Configuration of stable expression plasmid of insuline and process for efficient introduction to body
11/27/2002	CN1381583A Human papillomavirus E6/E7 fusion gene and its efficient expression carrier and fusion protein vaccine
11/27/2002	CN1381461A Light chain or heavy chain variable region gene of human liver cancer monoclonal antibody HAb18 and its application
11/26/2002	US6486299 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/26/2002	US6486134 Administering exogenous genes
11/26/2002	US6486133 Methods for inducing localized vascular development and enhancing the repair of a wound in the mammamian dermis
11/26/2002	US6486132 Immunomodulator, immunomodulator food and immunomodulator feed
11/26/2002	US6486131 As diagnostic and therapeutic assays and reagents for detecting and therapy of proliferative disorders arising from, for example, tumorigenic transformation of cells, or other hyperplastic or neoplastic transformation processes
11/26/2002	US6486122 Methods of increasing body weight in a subject by administering TGF-α
11/26/2002	US6485977 Recombinant constructs and techniques for delivering to eucaryotic cells bacterial proteins that are secreted via type III secretion systems
11/26/2002	US6485976 Use of adeno-associated virus (AAV) to deliver genes
11/26/2002	US6485973 Oligonucleotides specific for the marORAB operon
11/26/2002	US6485960 Polycystic kidney disease 1 gene and uses thereof
11/26/2002	US6485958 Method for producing recombinant adenovirus
11/26/2002	US6485955 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
11/26/2002	US6485934 Regulatory system for inducible expression of genes with lambdoid promoters
11/26/2002	US6485911 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 2 (PS-2) gene
11/26/2002	US6485729 An anti-influenza vaccine, wherein the improvement comprises having as an additive a substantially pure, influenza neuraminidase and influenza hemagglutinin protein
11/26/2002	US6485722 Method for selective engraftment of drug-resistant hematopoietic stem cells
11/26/2002	US6485721 Treating diabetes, comprising transplanting artificial skin of biopolymer and skin fibroblasts and/or epidermal cells transformed with a recombinant expression vector expressing human proinsulin and/or insulin
11/26/2002	US6485720 Transgene expression systems
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/21/2002	WO2002093519A2 Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
11/21/2002	WO2002092854A2 Genes expressed in breast cancer as prognostic and therapeutic targets
11/21/2002	WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092840A2 Agents that regulate apoptosis
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092825A2 Retroviral vectors for gene therapy
11/21/2002	WO2002092821A1 Novel maxizyme
11/21/2002	WO2002092817A1 Functions for d52 and ra006 nucleic acids and polypeptides
11/21/2002	WO2002092816A1 Replication vector showing cell-specific expression
11/21/2002	WO2002092812A1 ARTIFICIAL HUMAN CHROMOSOME CONTAINING HUMAN ANTIBODY μ LIGHT CHAIN GENE
11/21/2002	WO2002092808A1 Random gene unidirectional antisense library
11/21/2002	WO2002092807A1 Unigene unidirectional antisense library
11/21/2002	WO2002092798A2 Regulation of human phosphatidic acid phosphatase type 2c-like protein
11/21/2002	WO2002092796A1 Papilloma pseud-virus and it's preparation
11/21/2002	WO2002092795A2 Intracellular bonding of costimulatory molecules
11/21/2002	WO2002092788A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092772A2 Antisense modulation of ptp1b expression
11/21/2002	WO2002092667A1 Biodegradable polyphosphates for controlled release of bioactive substances
11/21/2002	WO2002092626A2 Cleavage and polyadenylation complex of precursor mrna
11/21/2002	WO2002092624A2 G-protein coupled receptor
11/21/2002	WO2002092617A1 Combined approach to treatment of cancer using a c-myc antisense oligomer
11/21/2002	WO2002092616A1 Antisense permeation enhancers
11/21/2002	WO2002092558A1 Polythiourea lipid derivatives
11/21/2002	WO2002092554A1 Complexes for transferring substances of interest into a cell
11/21/2002	WO2002092134A1 Lentiviral vectors encoding clotting factors for gene therapy
11/21/2002	WO2002092133A1 Angiogenesis inhibitors
11/21/2002	WO2002092128A1 Compositions and methods to regulate serum phosphate
11/21/2002	WO2002092127A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26
11/21/2002	WO2002092122A2 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	WO2002092069A1 Permeation enhancers
11/21/2002	WO2002092016A2 Therapeutic use of rank antagonists
11/21/2002	WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions

1 ... 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 ... 870